Journey Medical (DERM) Current Assets (2020 - 2026)
Journey Medical's (DERM) quarterly Current Assets came in at $65.0 million in Q1 2026, up 20.34% YoY from $54.0 million in Q1 2025, and down 2.85% on a QoQ basis from $66.9 million in Q4 2025.
Journey Medical (DERM) Current Assets (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Current Assets data on file, last reported at $65.0 million in Q1 2026.
- Quarterly Current Assets rose 20.34% year-over-year to $65.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.0 million (up 20.34% YoY) and the FY2025 annual result came in at $66.9 million, up 38.8% from the prior year.
- Current Assets slipped to $65.0 million in Q1 2026, from $66.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $90.3 million in Q1 2022 to a low of $44.7 million in Q3 2023.
- A 5-year average of $60.1 million and a median of $56.4 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets plunged 43.86% — and 2025, when it soared 38.8%.
- Tracing DERM's Current Assets over 5 years: stood at $77.7 million in 2022, then declined by 27.32% to $56.5 million in 2023, then slipped by 14.66% to $48.2 million in 2024, then soared by 38.8% to $66.9 million in 2025, then decreased by 2.85% to $65.0 million in 2026.
- The last three Current Assets figures came in at $65.0 million (Q1 2026), $66.9 million (Q4 2025), and $56.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Journey Medical | 201.80 Mn | 176.16 Mn | 12.37 Mn | 72.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.78 Mn |
| Mar 31, 2026 | 64.97 Mn |
| Dec 31, 2025 | 66.87 Mn |
| Sep 30, 2025 | 56.39 Mn |
| Jun 30, 2025 | 51.27 Mn |
| Mar 31, 2025 | 53.99 Mn |
| Dec 31, 2024 | 48.18 Mn |
| Sep 30, 2024 | 46.16 Mn |
| Jun 30, 2024 | 46.47 Mn |
| Mar 31, 2024 | 47.01 Mn |
| Dec 31, 2023 | 56.46 Mn |
| Sep 30, 2023 | 44.69 Mn |
| Jun 30, 2023 | 47.68 Mn |
| Mar 31, 2023 | 60.72 Mn |
| Dec 31, 2022 | 77.68 Mn |
| Sep 30, 2022 | 79.60 Mn |
| Jun 30, 2022 | 83.90 Mn |
| Mar 31, 2022 | 90.26 Mn |
| Dec 31, 2021 | 84.49 Mn |
| Sep 30, 2021 | 66.80 Mn |